<SEC-DOCUMENT>0000950103-25-015792.txt : 20251205
<SEC-HEADER>0000950103-25-015792.hdr.sgml : 20251205
<ACCEPTANCE-DATETIME>20251205124019
ACCESSION NUMBER:		0000950103-25-015792
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20251205
DATE AS OF CHANGE:		20251205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251552080

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251552081

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp238441_424b2-us25a3387d.htm
<DESCRIPTION>PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red"><FONT STYLE="font-size: 9pt">The
    information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these
    securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product
    supplement, underlying supplement, prospectus supplement and prospectus are not an offer to sell these securities, nor are they soliciting
    an offer to buy these securities, in any state where the offer or sale is not permitted.</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red"><FONT STYLE="font-size: 9pt">SUBJECT
TO COMPLETION, DATED DECEMBER 5, 2025</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%; font-size: 30pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="width: 45%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt; color: #888888"><B>December
</B></FONT><B><FONT STYLE="font-size: 9pt; color: white">---</FONT></B><B><FONT STYLE="font-size: 9pt; color: #888888">, 2025</FONT></B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: #888888"><FONT STYLE="font-size: 9pt"><B>Medium-Term
Senior Notes, Series N</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: #888888"><FONT STYLE="font-size: 9pt"><B>Pricing
Supplement No. 2025-USNCH29599</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: #888888"><FONT STYLE="font-size: 9pt"><B>Filed
Pursuant to Rule 424(b)(2)</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: #888888"><FONT STYLE="font-size: 9pt"><B>Registration
Statement Nos. 333-270327 and 333-270327-01</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="color: #296DC1; font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Autocallable Dual Directional Buffered PLUS Based on
the TOPIX<SUP>&reg;</SUP> Index Due January&nbsp;&nbsp;&nbsp;&nbsp; , 2028</P>

<P STYLE="color: #296DC1; font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="color: #888888; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Autocallable
Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP><BR STYLE="clear: none">
</B></FONT><B>Principal at Risk Securities</B></P>

<P STYLE="color: #888888; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Overview</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.35pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offered by this pricing supplement are unsecured debt securities issued by Citigroup Global Markets Holdings Inc. and
guaranteed by Citigroup Inc.&nbsp;&nbsp;Unlike conventional debt securities, the securities do not pay interest and do not repay a fixed
amount of principal at maturity. Instead, the securities offer a payment at maturity that may be greater than, equal to or less than the
stated principal amount, depending on the performance of the TOPIX<SUP>&reg; </SUP>Index (the &ldquo;underlying index&rdquo;) from the
initial index level to the final index level.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.35pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offer the opportunity for automatic early redemption at a premium if the closing level of the underlying index on the
interim valuation date is greater than or equal to the initial index level.&nbsp;&nbsp;If the closing level of the underlying index on
the interim valuation date is less than the initial index level, the securities will not be automatically redeemed at a premium and, instead,
the securities offer a payment at maturity reflecting leveraged exposure to the potential appreciation of the underlying index from the
initial index level to the final index level and a limited buffer against the potential depreciation of the underlying index as described
below. In addition, if the underlying index depreciates within a limited range (not more than the buffer amount specified below), the
securities provide for an unleveraged positive return at maturity based on the absolute value of that depreciation. In exchange for these
features, investors in the securities must be willing to forgo (i) positive participation in the absolute value of any depreciation in
excess of the buffer amount and (ii) any dividends that may be paid on the stocks that constitute the underlying index. In addition, investors
in the securities must be willing to accept downside exposure to any depreciation of the underlying index in excess of the buffer amount.
<B>If the underlying index depreciates by more than the buffer amount from the pricing date to the final valuation date, you will lose
1% of the stated principal amount of your securities for every 1% by which that depreciation exceeds the buffer amount.&nbsp;&nbsp;</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.35pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>In order to obtain the modified exposure to the underlying index that the securities provide, investors must be willing to accept
(i) an investment that may have limited or no liquidity and (ii) the risk of not receiving any amount due under the securities if we and
Citigroup Inc. default on our obligations. <B>All payments on the securities are subject to the credit risk of Citigroup Global Markets
Holdings Inc. and Citigroup Inc.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #296DC1">
    <TD COLSPAN="4"><FONT STYLE="color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Issuer:</B></FONT></TD>
    <TD COLSPAN="3">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Guarantee:</B></FONT></TD>
    <TD COLSPAN="3">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Underlying index: </B></FONT></TD>
    <TD COLSPAN="3">The TOPIX<SUP>&reg;</SUP> Index (ticker symbol: &ldquo;TPX&rdquo;)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Aggregate stated principal amount:</B></FONT></TD>
    <TD COLSPAN="3">$</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Stated principal amount: </B></FONT></TD>
    <TD COLSPAN="3">$1,000 per security</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Pricing date:</B></FONT></TD>
    <TD COLSPAN="3">December&nbsp;&nbsp;&nbsp;&nbsp; , 2025 (expected to be December 26, 2025)</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Issue date:</B></FONT></TD>
    <TD COLSPAN="3">December&nbsp;&nbsp;&nbsp;&nbsp; , 2025 (expected to be December 31, 2025)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Final valuation date: </B></FONT></TD>
    <TD COLSPAN="3">December&nbsp;&nbsp;&nbsp;&nbsp; , 2027 (expected to be December 29, 2027), subject to postponement if such date is not a scheduled trading day or if certain market disruption events occur</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Maturity date: </B></FONT></TD>
    <TD COLSPAN="3">January&nbsp;&nbsp;&nbsp;&nbsp; , 2028 (expected to be January 3, 2028)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Interim valuation date:</B></FONT></TD>
    <TD COLSPAN="3">Expected to be January 4, 2027, subject to postponement if such date is not a scheduled trading day or certain market disruption events occur with respect to the underlying index</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="color: #296DC1"><B>Automatic early redemption:</B></FONT></TD>
    <TD COLSPAN="3">If the closing level of the underlying index on the interim valuation date is greater than or equal to the initial index level, the securities will be automatically redeemed on the third business day following the interim valuation date for an amount in cash per security equal to $1,000 plus the premium applicable to the interim valuation date.&nbsp;&nbsp;If the securities are automatically redeemed following the interim valuation date, they will cease to be outstanding and you will not be entitled to receive the payment that otherwise would have been due at maturity. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Payment at maturity:</B></FONT></TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities have not previously been redeemed, you will receive
    at maturity, for each $1,000 stated principal amount security you then hold:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings">&sect;&#9;</FONT>&nbsp;If
    the final index level is <B>greater than </B>the initial index level:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: -0.25in"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: 0.5in">$1,000 + the leveraged return amount</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: 0.5in"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings">&sect;&#9;</FONT>&nbsp;If
    the final index level is <B>equal to</B> the initial index level or <B>less than</B> the initial index level by an amount <B>less than
    or equal to</B> the buffer amount:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: -0.25in"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: 0.5in">$1,000 + ($1,000 &times; the absolute
    index return)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: 0.5in"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings">&sect;&#9;</FONT>&nbsp;If
    the final index level is <B>less than</B> the initial index level by an amount <B>greater than</B> the buffer amount:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: -0.25in"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: 0.5in">$1,000 + [$1,000 &times; (the index return
    + the buffer amount)]</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: 0.5in"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the final index level is less than the initial index level
by more than the buffer amount, your payment at maturity will be less, and possibly significantly less, than the $1,000 stated principal
amount per security. You should not invest in the securities unless you are willing and able to bear the risk of losing a significant
portion of your investment.</B></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Initial index level: </B></FONT></TD>
    <TD COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, the closing level of the underlying index on the pricing date</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Leveraged return amount:</B></FONT></TD>
    <TD COLSPAN="3">$1,000 &times; the index return &times; the upside leverage factor</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Upside leverage factor:&#9;</B></FONT></TD>
    <TD COLSPAN="3">150%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: #296DC1"><B>Absolute index return<FONT STYLE="font-size: 10pt">:</FONT></B></FONT></TD>
    <TD COLSPAN="3">The absolute value of the index return</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Buffer amount:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">10.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Listing:</B></FONT></TD>
    <TD COLSPAN="3">The securities will not be listed on any securities exchange</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Underwriter:</B></FONT></TD>
    <TD COLSPAN="3">Citigroup Global Markets Inc. (&ldquo;CGMI&rdquo;), an affiliate of the issuer, acting as principal</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Issue price</B></FONT><B><FONT STYLE="color: #296DC1"><SUP>(1)(2) </SUP></FONT></B></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Underwriting fee</B></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Proceeds to issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center">$1,000.00</TD>
    <TD STYLE="text-align: center">$20.00<FONT STYLE="color: #296DC1"><B><SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="text-align: center">$975.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">$5.00<FONT STYLE="color: #296DC1"><B><SUP>(3)</SUP></B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center">$</TD>
    <TD STYLE="text-align: center">$</TD>
    <TD STYLE="text-align: center">$</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 8pt"><I>(Key Terms continued
on next page)</I></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">(1) Citigroup Global Markets Holdings
Inc. currently expects that the estimated value of the securities on the pricing date will be at least $914.00 per security, which will
be less than the issue price.&nbsp;&nbsp;The estimated value of the securities is based on CGMI&rsquo;s proprietary pricing models and
our internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the
price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time after issuance.&nbsp;&nbsp;See
&ldquo;Valuation of the Securities&rdquo; in this pricing supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">(2) CGMI, an affiliate of Citigroup Global
Markets Holdings Inc. and the underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee
of $25.00 for each $1,000.00 security sold in this offering.&nbsp;&nbsp;Certain selected dealers, including Morgan Stanley Wealth Management,
and their financial advisors will collectively receive from CGMI a fixed selling concession of $20.00 for each $1,000.00 security they
sell.&nbsp;&nbsp;Additionally, it is possible that CGMI and its affiliates may profit from expected hedging activity related to this
offering, even if the value of the securities declines.&nbsp;&nbsp;See &ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying
prospectus.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">(3) Reflects a structuring fee payable
to Morgan Stanley Wealth Management by CGMI of $5.00 for each security.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-7.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of the securities or determined that this pricing
supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are truthful or complete.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying product supplement, underlying supplement, prospectus supplement and prospectus, each of which can be accessed via
the hyperlinks below:</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #296DC1"><B><U><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003818/dp190217_424b2-ea0210.htm" STYLE="color: rgb(41,109,193)">Product Supplement No. EA-02-10 dated March 7, 2023</A></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm" STYLE="color: rgb(41,109,193)">Underlying Supplement No. 11 dated March 7, 2023</A></U></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #296DC1"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #296DC1"><B><U><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(41,109,193)">Prospectus Supplement and Prospectus each dated March 7, 2023</A></U></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #296DC1"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #296DC1 1pt solid">
    <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on
    the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P>
    <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable
    Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #296DC1">
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS (continued)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Premium:</B></FONT></TD>
    <TD STYLE="width: 81%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The premium applicable to the interim valuation date is the amount indicated
    below.&nbsp;&nbsp;<B>The premium may represent a return that is significantly less than the appreciation of the underlying index from
    the pricing date to the interim valuation date.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 24.5pt">&bull;&#9;January 4, 2027:&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.25% of the stated principal
amount</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Final index level:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The closing level of the underlying index on the final valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Index return:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(i) The final index level <I>minus </I>the initial index level, <I>divided by</I> (ii) the initial index level</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD><FONT STYLE="font-size: 10pt; color: #296DC1"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">17331B3T4 / US17331B3T45</FONT></TD></TR>
  </TABLE>
<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; color: #296DC1; margin: 0pt 0">Additional Information</P>

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the securities are set forth in the accompanying product
supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement, prospectus
supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, certain events
may occur that could affect whether the securities are automatically redeemed or your payment at maturity. These events and their consequences
are described in the accompanying product supplement in the sections &ldquo;Description of the Securities&mdash;Consequences of a Market
Disruption Event; Postponement of a Valuation Date&rdquo; and &ldquo;Description of the Securities&mdash;Certain Additional Terms for
Securities Linked to an Underlying Index&mdash;Discontinuance or Material Modification of an Underlying Index,&rdquo; and not in this
pricing supplement. The accompanying underlying supplement contains important disclosures regarding the underlying index that are not
repeated in this pricing supplement. It is important that you read the accompanying product supplement, underlying supplement, prospectus
supplement and prospectus together with this pricing supplement in deciding whether to invest in the securities. Certain terms used but
not defined in this pricing supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Investment Summary</P>

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities can be used:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="font-size: 10pt">To provide an opportunity to earn a premium upon automatic early redemption if the closing level of
the underlying index on the interim valuation date is greater than or equal to the initial index level;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="font-size: 10pt">As an alternative to direct exposure to the underlying index that, if the securities are not redeemed
prior to maturity, enhances <FONT STYLE="background-color: white">returns for any positive performance of the underlying index</FONT>;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="font-size: 10pt">If the securities are not redeemed prior to maturity, to enhance returns and outperform the underlying
index in a bullish scenario, without taking into account lost dividend yield;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="font-size: 10pt">If the securities are not redeemed prior to maturity, to achieve similar levels of upside exposure to
the underlying index as a direct investment, while using fewer dollars by taking advantage of the upside leverage factor;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="font-size: 10pt">If the securities are not redeemed prior to maturity, to obtain a positive return for a limited range
of negative performance of the underlying index; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="font-size: 10pt">If the securities are not redeemed prior to maturity, to obtain a limited buffer against the potential
depreciation of the underlying index.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the underlying index depreciates by more than the buffer amount,
the securities are exposed on a 1-to-1 basis to the percentage decline in the underlying index beyond the buffer amount. Accordingly,
investors may lose a significant portion of their initial investment in the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="background-color: #DCEBF4">
    <TD STYLE="width: 30%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Maturity:</B></FONT></TD>
    <TD STYLE="width: 70%; font-size: 12pt"><FONT STYLE="font-size: 10pt">Approximately two years</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Upside leverage factor: </B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">150%. The upside leverage factor applies only if the final index level is greater than the initial index level.</FONT></TD></TR>
  <TR STYLE="background-color: #DCEBF4">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Buffer amount:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">10.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Minimum payment at maturity:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">$100.00 per security (10.00% of the stated principal amount). Investors may lose up to 90.00% of the stated principal amount of the securities.</FONT></TD></TR>
  <TR STYLE="background-color: #DCEBF4">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>Interest:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">None</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Key Investment Rationale</P>

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The securities offer the opportunity
for automatic early redemption at a premium if the closing level of the underlying index on the interim valuation date is greater than
or equal to the initial index level. If the securities are not redeemed prior to maturity, the securities offer the potential for, at
maturity, (i) a leveraged return if the underlying index appreciates and (ii) if the underlying index depreciates, an unleveraged positive
return equal to the absolute value of the depreciation of the underlying index, but only so long as the underlying index does not depreciate
by more than the buffer amount from the initial index level to the final index level. At maturity (assuming the securities are not automatically
redeemed prior to maturity), if the underlying index has <B>appreciated</B> from the initial i</FONT>ndex level <FONT STYLE="background-color: white">to
the final i</FONT>ndex level<FONT STYLE="background-color: white">, investors will receive the stated principal amount of their investment
plus the leveraged upside performance of the underlying index. If the underlying index has <B>depreciated </B>from the initial index level
to the final index level, but not by more than the buffer amount, investors will receive the stated principal amount of their investment
plus a positive return equal to the absolute value of the percentage decline, which will effectively be limited to a positive return of
10.00%.&nbsp;&nbsp;However, if the underlying index has <B>depreciated</B> by more than the buffer amount from the initial index level
to the final index level, investors will lose 1% of the stated principal amount for every 1% by which that depreciation exceeds the buffer
amount. Under these circumstances, the payment at maturity will be less, and possibly significantly less, than the stated principal amount.
<B>Investors may lose up to 90% of the stated principal amount of the securities.</B> All payments on the securities are subject to the
credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 17%; border: white 1.5pt solid; background-color: #DCEBF4; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Premium: </B></FONT></TD>
    <TD STYLE="width: 83%; font-size: 12pt"><FONT STYLE="font-size: 10pt; background-color: white">The securities offer investors the opportunity for automatic early redemption at a premium following the interim valuation date if the closing level of the underlying index on the interim valuation date is greater than or equal to the initial index level.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #DCEBF4; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Leveraged Upside Performance:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; background-color: white">If the securities are not automatically redeemed prior to maturity, the securities offer investors an opportunity at maturity to capture enhanced returns relative to a direct investment in the underlying index if the underlying index appreciates.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #DCEBF4; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Absolute Return Feature:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; background-color: white">If the securities are not automatically redeemed prior to maturity, the securities offer the potential for an unleveraged positive return at maturity if the underlying index depreciates by an amount <B>less than or equal to</B> the buffer amount, which means that the underlying index has depreciated by no more than 10.00% from its initial index level.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #DCEBF4; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Upside Scenario if the Underlying Index Appreciates:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; background-color: white">If the final index level is greater than the initial index level, the payment at maturity for each security will be equal to the $1,000 stated principal amount plus the product of (i) the stated principal amount, (ii) the upside leverage factor and (iii) the index return.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #DCEBF4; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Absolute Return Scenario:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; background-color: white">If the final index level is equal to the initial index level or less than the initial index level by an amount less than or equal to the buffer amount, which means that the underlying index has depreciated by no more than 10.00% from the initial index level, you will receive a 1% positive return on the securities for each 1% negative return on the underlying index. For example, if the final index level is 5% less than the initial index level, the securities will provide a positive return of 5% at maturity. The maximum return you may receive in this scenario is a positive 10.00% return at maturity.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #DCEBF4; layout-grid-mode: char; color: #296DC1; font-weight: bold"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Downside Scenario:</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; background-color: white">If the securities are not automatically redeemed prior to maturity and the final index level is <B>less than</B> the initial index level by more than the buffer amount, which means that the underlying index has depreciated by more than 10.00% from its initial index level, you will lose 1% of the stated principal amount for every 1% by which that depreciation exceeds the buffer amount (e.g., a 50% depreciation in the underlying index will result in a payment at maturity of $600.00 per security). The minimum payment at maturity is $100.00 per security. Accordingly, investors may lose a significant portion of their initial investment.</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Hypothetical Examples</P>

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The diagram and examples below illustrate how the payment at maturity
will be calculated if the securities are not automatically redeemed prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investors in the securities will not receive any dividends that may
be paid on the stocks that constitute the underlying index. The diagram and examples below do not show any effect of lost dividend yield
over the term of the securities.</B> See &ldquo;Summary Risk Factors&mdash;Investing in the securities is not equivalent to investing
in the underlying index or the stocks that constitute the underlying index&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD COLSPAN="2" STYLE="border: Black 1pt solid">
    <P STYLE="color: #296DC1; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Autocallable Dual Directional
    Buffered PLUS</P>
    <P STYLE="color: #296DC1; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="color: #296DC1; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Payment at Maturity Diagram
(Assuming No Automatic Early Redemption)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><IMG SRC="image_001.gif" ALT="" STYLE="height: 480px; width: 720px"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%; border-left: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Wingdings; color: #296DC1">n</FONT>&nbsp;The&nbsp;Securities&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 47%; border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Wingdings">n</FONT>&nbsp;The Underlying Index</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the hypothetical initial index level
of 100.00 and do not reflect the actual initial index level. For the actual initial index level, see the cover page of this pricing supplement.
We have used this hypothetical value, rather than the actual value, to simplify the calculations and aid understanding of how the securities
work. However, you should understand that the actual payment at maturity on the securities will be calculated based on the actual initial
index level and not the hypothetical value indicated below. For ease of analysis, figures below may have been rounded.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1&mdash;Upside Scenario A.</B> The hypothetical final index
level is 105.00 (a 5.00% increase from the hypothetical initial index level), which is <B>greater than</B> the hypothetical initial index
level.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + the leveraged return amount</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 <FONT STYLE="background-color: white">&times; the
index return &times; the upside leverage factor)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= <FONT STYLE="background-color: white">$1,000 + ($1,000 &times; 5.00%
&times; 150%)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + $75.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,075.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Because the underlying index appreciated
from the hypothetical initial </FONT>index level <FONT STYLE="background-color: white">to the hypothetical final </FONT>index level<FONT STYLE="background-color: white">,
your payment at maturity in this scenario would be equal to the $1,000 stated principal amount per security <I>plus</I> the leveraged
return amount, or $1,075</FONT>.00 <FONT STYLE="background-color: white">per security.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2&mdash;Upside Scenario B. </B>The hypothetical final index
level is 95.00 (a 5.00% decrease from the hypothetical initial index level), which is <B>less than</B> the hypothetical initial index
level by an amount that is <B>less than</B> the buffer amount of 10.00%.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + ($1,000 &times; the absolute
index return)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; |-5.00%|)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">=$1,000 + $50.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,050.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Because the underlying index depreciated from the hypothetical initial
index level to the hypothetical final index level by less than the 10.00% buffer amount, your payment at maturity in this scenario would
reflect 1-to-1 positive exposure to the absolute value of the negative performance of the underlying index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3&mdash;Downside Scenario.</B> The hypothetical final index
level is 30.00 (a 70.00% decrease from the hypothetical initial index level), which is <B>less than</B> the hypothetical initial index
level by an amount that is <B>more than</B> the buffer amount of 10.00%.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + [$1,000 &times; (the index
return + the buffer amount)]</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + [$1,000 &times; (-70.00% + 10.00%)]</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + [$1,000 &times; (-60.00%)]</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + -$600.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $400.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Because the underlying index depreciated from the hypothetical initial
index level to the hypothetical final index level by more than the 10.00% buffer amount, your payment at maturity in this scenario would
reflect 1-to-1 downside exposure to the negative performance of the underlying index beyond the 10.00% buffer amount.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Summary Risk Factors</P>

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities.&nbsp;&nbsp;The securities are subject to all of the risks associated with an investment in our conventional
debt securities that are guaranteed by Citigroup Inc., including the risk that we and Citigroup Inc. may default on our obligations under
the securities, and are also subject to risks associated with the underlying index.&nbsp;&nbsp;Accordingly, the securities are appropriate
only for investors who are capable of understanding the complexities and risks of the securities.&nbsp;&nbsp;You should consult your own
financial, tax and legal advisors as to the risks of an investment in the securities and the appropriateness of the securities in light
of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities.&nbsp;&nbsp;You should read this summary together with the more detailed description of risks relating to an investment
in the securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying
product supplement.&nbsp;&nbsp;You should also carefully read the risk factors included in the accompanying prospectus supplement and
in the documents incorporated by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report
on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may lose up to 90.00% of your investment. </B>Unlike conventional debt securities, the securities do not repay a fixed amount
of principal at maturity. Instead, your payment at maturity will depend on the performance of the underlying index. If the securities
are not automatically redeemed prior to maturity and the final index level depreciates by more than the buffer amount, you will lose 1%
of the stated principal amount of the securities for every 1% by which that depreciation exceeds the buffer amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities do not pay interest.</B>&nbsp;&nbsp;Unlike conventional debt securities, the securities do not pay interest or any
other amounts prior to maturity. You should not invest in the securities if you seek current income during the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>Your potential for positive participation in the absolute value of any depreciation of the
underlying index is limited.</B> Because the buffer&nbsp;amount is equal to 10.00%, the return potential of the securities in the event
that the underlying index depreciates is limited to 10.00%. Any depreciation of the underlying index in excess of the buffer amount will
result in a loss, rather than a positive return, on the securities.&nbsp;&nbsp; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Investing in the securities is not equivalent to investing in the underlying index or the stocks that constitute the underlying
index. </B>You will not have voting rights, rights to receive dividends or other distributions or any other rights with respect to the
stocks that constitute the underlying index. The payment scenarios described in this pricing supplement do not show any effect of lost
dividend yield over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Your return on the securities depends on the closing level of the underlying index on a limited number of days.&nbsp;&nbsp;</B>Because
your payment upon automatic early redemption, if applicable, or at maturity depends on the closing level of the underlying index solely
on one of the valuation dates, you are subject to the risk that the closing level of the underlying index on those days may be lower,
and possibly significantly lower, than on one or more other dates during the term of the securities. If you had invested in another instrument
linked to the underlying index that you could sell for full value at a time selected by you, or if the return on the securities was based
on an average of closing levels of the underlying index, you might have achieved better returns.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>If the securities are redeemed prior to maturity, the appreciation potential of the securities is limited by the early redemption
payment specified for the interim valuation date. </B>If the closing level of the index on the interim valuation date is greater than
or equal to the initial index level, you will be repaid the stated principal amount of your securities and will receive the fixed premium
applicable to the interim valuation date, regardless of how significantly the closing level of the index on the interim valuation date
may exceed the initial index level. Accordingly, the premium may result in a return on the securities that is significantly less than
the return you could have achieved on a direct investment in the underlying index.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The term of the securities may be as short as one year.</B>&nbsp;&nbsp;If the closing level of the index on the interim valuation
date, expected to occur approximately one year after the pricing date, is greater than or equal to the initial index level, the securities
will be automatically redeemed. Additionally, if the securities are redeemed prior to maturity, you may not be able to reinvest at comparable
terms or returns.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.&nbsp;&nbsp;</B>If we
default on our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything
owed to you under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.</B> The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, will be less than the issue price.</B> The difference is attributable to certain costs associated with selling, structuring and
hedging the securities that are included in the issue price. These costs include (i) the selling concessions and structuring fees paid
in connection with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the
offering of the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates
in connection with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities because,
if they were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities are also
likely to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities.
See &ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.</B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of the underlying index, dividend yields on the stocks
that constitute the underlying index and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo; views,
and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models may
prove to be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities
set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities
for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated value of the securities.
Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities
from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate,
rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences. Our internal funding rate is not an interest rate that we will pay to investors in the securities, which do not
bear interest.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Because there is not an active market for
traded instruments referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of
traded instruments referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the
securities, but subject to adjustments that CGMI makes in its sole discretion.&nbsp;&nbsp;As a result, our secondary market rate is not
a market-determined measure of our creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness
as adjusted for discretionary factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market
rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition, any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.
As a result, it is likely that any secondary market price for the securities will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors. </B>The value of your securities
prior to maturity will fluctuate based on the level and volatility of the underlying index and a number of other factors, including the
price and volatility of the stocks that constitute the underlying index, the dividend yields on the stocks that constitute the underlying
index, interest rates generally, the time remaining to maturity and our and/or Citigroup Inc.&rsquo;s creditworthiness, as reflected in
our secondary market rate. Changes in the level of the underlying index may not result in a comparable change in the value of your securities.
You should understand that the value of your securities at any time prior to maturity may be significantly less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.</B> The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The TOPIX<SUP>&reg;</SUP>&nbsp;Index is subject to risks associated with non-U.S. markets.&nbsp;</B>Investments in securities linked
to the value of non-U.S. stocks involve risks associated with the securities markets in those countries, including risks of volatility
in those markets, governmental intervention in those markets and cross shareholdings in companies in certain countries. Also, there is
generally less publicly available information about companies in some of these jurisdictions than about U.S. companies that are subject
to the reporting requirements of the SEC. Further, non-U.S. companies are generally subject to accounting, auditing and financial reporting
standards and requirements and securities trading rules that are different from those applicable to U.S. reporting companies. The prices
of securities in foreign markets may be affected by political, economic, financial and social factors in those countries, or global regions,
including changes in government, economic and fiscal policies and currency exchange laws. Moreover, the economies in such countries may
differ favorably or unfavorably from the economy of the United States in such respects as growth of gross national product, rate of inflation,
capital reinvestment, resources and self-sufficiency.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The performance of the TOPIX<SUP>&reg;</SUP> Index will not be adjusted for changes in the exchange rate between the Japanese yen
and the U.S. dollar.</B> The TOPIX<SUP>&reg;</SUP> Index is composed of stocks traded in Japanese yen, the value of which may be subject
to a high degree of fluctuation relative to the U.S. dollar.&nbsp;&nbsp;However, the performance of the TOPIX<SUP>&reg;</SUP> Index and
the value of your securities will not be adjusted for exchange rate fluctuations.&nbsp;&nbsp;If the Japanese yen appreciates relative
to the U.S. dollar over the term of the securities, your return on the securities will underperform an alternative investment that offers
exposure to that appreciation in addition to the change in the level of the TOPIX<SUP>&reg;</SUP> Index.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Governmental regulatory actions, such as sanctions, could adversely affect your investment in the securities.</B> Governmental
regulatory actions, including, without limitation, sanctions-related actions by the U.S. or a foreign government, could prohibit or otherwise
restrict persons from holding the securities or underlying shares, or engaging in transactions in them, and any such action could adversely
affect the value of underlying shares. These regulatory actions could result in restrictions on the securities and could result in the
loss of a significant portion or all of your initial investment in the securities, including if you are forced to divest the securities
due to the government mandates, especially if such divestment must be made at a time when the value of the securities has declined.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Our offering of the securities does not constitute a recommendation of the underlying index. </B>The fact that we are offering
the securities does not mean that we believe that investing in an instrument linked to the underlying index is likely to achieve favorable
returns. In fact, as we are part of a global financial institution, our affiliates may have positions (including short positions) in the
stocks that constitute the underlying index or in instruments related to the underlying index or such stocks, and may publish research
or express opinions, that in each case are inconsistent with an investment linked to the underlying index. These and other activities
of our affiliates may affect the level of the underlying index in a way that has a negative impact on your interests as a holder of the
securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The level of the underlying index may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>
We expect to hedge our obligations under the securities through CGMI or other of our affiliates, who may take positions directly in the
stocks that constitute the underlying index and other financial instruments related to the underlying index or such stocks and may adjust
such positions during the term of the securities. Our affiliates also trade the stocks that constitute the underlying index and other
financial instruments related to the underlying index or such stocks on a regular basis (taking long or short positions or both), for
their accounts, for other accounts under their management or to facilitate transactions on behalf of customers. These activities could
affect the level of the underlying index in a way that negatively affects the value of the securities. They could also result in substantial
returns for us or our affiliates while the value of the securities declines.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.
</B>Our affiliates may currently or from time to time engage in business with the issuers of the stocks that constitute the underlying
index, including extending loans to, making equity investments in or providing advisory services to such issuers. In the course of this
business, we or our affiliates may acquire non-public information about such issuers, which we will not disclose to you. Moreover, if
any of our affiliates is or becomes a creditor of any such issuer, they may exercise any remedies against any such issuer that are available
to them without regard to your interests.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B>&nbsp;&nbsp;If
certain events occur, such as market disruption events or the discontinuance of the underlying index, CGMI, as calculation agent, will
be required to make discretionary judgments that could significantly affect your payment at maturity.&nbsp;&nbsp;In making these judgments,
the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Adjustments to the underlying index may affect the value of your securities. </B>The underlying index publisher may add, delete
or substitute the stocks that constitute the underlying index or make other methodological changes that could affect the level of the
underlying index. The underlying index publisher may discontinue or suspend calculation or publication of the underlying index at any
time without regard to your interests as holders of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the securities are unclear.&nbsp;&nbsp;</B>There is no direct legal authority
regarding the proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service
(the &ldquo;IRS&rdquo;).&nbsp;&nbsp;Consequently, significant aspects of the tax treatment of the securities are uncertain, and the IRS
or a court might not agree with the treatment of the securities as prepaid forward contracts.&nbsp;&nbsp;If the IRS were successful in
asserting an alternative treatment of the securities, the tax consequences of the ownership and disposition of the securities might be
materially and adversely affected.&nbsp;&nbsp;Moreover, future legislation, Treasury regulations or IRS guidance could adversely affect
the U.S. federal tax treatment of the securities, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">If you are a non-U.S. investor, you should review the discussion
of withholding tax issues in &ldquo;United States Federal Tax Considerations&mdash;Non-U.S. Holders&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">You should read carefully the discussion
under &ldquo;United States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying
product supplement and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement.&nbsp;&nbsp;You should also consult
your tax adviser regarding the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under
the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in; color: #296DC1">Information About the TOPIX<SUP>&reg;</SUP>
Index</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The TOPIX<SUP>&reg;</SUP> Index is a free float-adjusted market capitalization-weighted
index of common stocks listed on the Tokyo Stock Exchange covering an extensive portion of the Japanese stock market. The TOPIX<SUP>&reg;</SUP>
Index is calculated, maintained and published by JPX Market Innovation &amp; Research, Inc.&nbsp;&nbsp;The TOPIX<SUP>&reg;</SUP> Index
is reported by Bloomberg L.P. under the ticker symbol &ldquo;TPX.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The TOPIX<SUP>&reg;</SUP> trademarks, including &ldquo;TOPIX<SUP>&reg;</SUP>&rdquo;
and &ldquo;TOPIX<SUP>&reg;</SUP> Index,&rdquo; are subject to the intellectual property rights owned by JPX Market Innovation &amp; Research,
Inc. and have been licensed for use by Citigroup Global Markets Inc. and its affiliates.&nbsp;&nbsp;For more information, see &ldquo;Equity
Index Descriptions&mdash;The TOPIX<SUP>&reg;</SUP> Index&mdash;License Agreement&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;
The TOPIX<SUP>&reg;</SUP> Index&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing level of the underlying index on December 3, 2025 was 3,334.32.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #296DC1; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: windowtext">The graph below shows
the closing level of the underlying index for each day such level was available from January 5, 2015 to December 3, 2025. We obtained
the closing levels from Bloomberg L.P., without independent verification. You should not take the historical levels of the underlying
index as an indication of future performance</FONT>.</P>

<P STYLE="color: #296DC1; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #DCEBF4">
    <TD STYLE="width: 100%; border: Black 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #296DC1"><B>TOPIX<SUP>&reg;</SUP> Index &ndash; Historical Closing Levels*<BR>
January 5, 2015 to December 3, 2025</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="color: black"><IMG SRC="image_002.gif" ALT="" STYLE="height: 315px; width: 577px"></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="color: black">*The red line indicates 90% of the closing level of the underlying index on December 3, 2025 as a hypothetical illustration of the buffer amount of 10.00%. The actual level below which you will lose some of your initial investment will be 90% of the initial index level.</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">United States Federal Tax Considerations</P>

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, a security
should be treated as a prepaid forward contract for U.S. federal income tax purposes.&nbsp;&nbsp;By purchasing a security, you agree (in
the absence of an administrative determination or judicial ruling to the contrary) to this treatment.&nbsp;&nbsp;There is uncertainty
regarding this treatment, and the IRS or a court might not agree with it. Moreover, our counsel&rsquo;s opinion is based on market conditions
as of the date of this preliminary pricing supplement and is subject to confirmation on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the securities is respected and subject to
the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>You should not recognize taxable income over the term of the securities prior to maturity, other than pursuant to a sale or exchange.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a security (including retirement at maturity), you should recognize capital gain or loss equal to the difference
between the amount realized and your tax basis in the security.&nbsp;&nbsp;Such gain or loss should be long-term capital gain or loss
if you held the security for more than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership
and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury Department
and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative
tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Non-U.S. Holders</B>. Subject to the discussions below and in &ldquo;United
States Federal Tax Considerations&rdquo; in the accompanying product supplement, if you are a Non-U.S. Holder (as defined in the accompanying
product supplement) of the securities, you generally should not be subject to U.S. federal withholding or income tax in respect of any
amount paid to you with respect to the securities, provided that (i) income in respect of the securities is not effectively connected
with your conduct of a trade or business in the United States, and (ii) you comply with the applicable certification requirements.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities.&nbsp;&nbsp;Section 871(m) generally applies to instruments that substantially replicate the economic
performance of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations.&nbsp;&nbsp;However,
the regulations, as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo;
of one.&nbsp;&nbsp;Based on the terms of the securities and representations provided by us as of the date of this preliminary pricing
supplement, our counsel is of the opinion that the securities should not be treated as transactions that have a &ldquo;delta&rdquo; of
one within the meaning of the regulations with respect to any U.S. Underlying Equity and, therefore, should not be subject to withholding
tax under Section 871(m).&nbsp;&nbsp;However, the final determination regarding the treatment of the securities under Section 871(m) will
be made as of the pricing date for the securities, and it is possible that the securities will be subject to withholding tax under Section
871(m) based on the circumstances as of that date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the securities are not subject to Section 871(m)
is not binding on the IRS, and the IRS may disagree with this treatment.&nbsp;&nbsp;Moreover, Section 871(m) is complex and its application
may depend on your particular circumstances, including your other transactions.&nbsp;&nbsp;You should consult your tax adviser regarding
the potential application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If withholding tax applies to the securities, we will not be required
to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement.&nbsp;&nbsp;The preceding discussion, when read in combination with that
section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning
and disposing of the securities.&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #296DC1 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: bottom"><TD STYLE="border-bottom: #296DC1 1pt solid"> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(41,109,193)">Autocallable Dual Directional Buffered PLUS Based on the TOPIX<SUP>&reg;</SUP> Index Due January , 2028</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #296DC1"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="background-color: white"><B>Autocallable Dual Directional Buffered Performance Leveraged Upside Securities<SUP>SM </SUP></B></FONT></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><B>Principal at Risk Securities</B></P></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Supplemental Plan of Distribution</P>

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of $25.00 for each $1,000 security
sold in this offering.&nbsp;&nbsp;From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI, including Morgan
Stanley Wealth Management, and their financial advisors collectively a fixed selling concession of $20.00 for each $1,000 security they
sell.&nbsp;&nbsp;In addition, Morgan Stanley Wealth Management will receive a structuring fee of $5.00 for each security they sell.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The costs included in the original issue price of the securities will
include a fee paid by CGMI to LFT Securities, LLC, an entity in which an affiliate of Morgan Stanley Wealth Management has an ownership
interest, for providing certain electronic platform services with respect to this offering.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; color: rgb(41,109,193); margin: 0pt 0">Valuation of the Securities</P>

<P STYLE="color: #296DC1; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The estimated value of the securities is a function of the terms of
the securities and the inputs to CGMI&rsquo;s proprietary pricing models.&nbsp;&nbsp;As of the date of this preliminary pricing supplement,
it is uncertain what the estimated value of the securities will be on the pricing date because it is uncertain what the values of the
inputs to CGMI&rsquo;s proprietary pricing models will be on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately three months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time.&nbsp;&nbsp;See &ldquo;Summary
Risk Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>&copy;</SUP> 2025 Citigroup Global Markets Inc. All rights reserved.
Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout
the world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="color: #296DC1">December 2025</FONT></TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #296DC1">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#=AT +@ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M(#]2YJGGGF(]<($'_TC0YD#;Y:- 0>(( "0 *_Z5W$ '/(@@@-J95U %,P(
MC03HF$DA@IOQ*>JHI$)U0 7L" "C=A6<0^% #7C_@,%LPYDS)J0",,"!!#UF
M5M"; A60#P<.[C 0L <Q<,"RKY;J[+,9J4/"M-,68.VUV&:K[;;<=NOMM^!Z
MRX ##DB'E+( [ !B! 8"\( &$81SD#D>+"JCAQT"$*F.0P9;;T$<Y#.0 AX<
M4(  _@Q400@)@9!  A#8!NW$%$?DPP+K+""""#P<0.['((<L\L@DEVSRR2B/
MS, .$PC@<J9&46"? \I9J1V\K1E4H\(9"%2!DP#<Z\ _YC: 74',8=G@/Y-%
M,.C.#$&P9,545VU0-@LLD$36/,C#C-=?,R,VV&&/+7;9:).M]MEKF^UVVFS'
M_7;;S(S;LLNJ)O6   F _P"! ^=8 $"K#A3PUZ':&:9C/(4?<$X_ AWP#PC?
M." !?P5H,$$Y#W '(#0,M/@ >(9S%Z,$A@G9+$()3&WUZQ7[P,T"W%2Q  _D
M,N. [KK+L[L#OO?^>_# #V^\\,@7GSSQS!^O_//-]\Y,/W<+\-E2!XSF@0<@
M[BW ]O'\$T&+]8%F3@+Y:, ]01Q$H$$^!N )@ /PNL],C+EB^,%EW0F$6OH2
M6-1"6@>[ DZ,!%NK @)N1X1PZ$X?RI"'UW8PP0HR@X(7M" &-ZC!#F;P@QP$
MH0=#N,&P,0 "D'%9!4*%%#^%P%P%6-8!^B'#8"4 '!4ZP/T*P@ 0M*,@Y5@6
M-/]@=0 B > X!B/( !QP ',UA( &C.*HLK&U)"2A"CR@0C@DV+LMAN-W7@2C
M/+ZHNS"6<8QB)*,#S+A&-)Y1C6R,HQO;2$9F8" $>!- !8S(% ;,BB'?B(:Q
M=@)%*1I22M#8&@)LQPTJK!&"7ML=!<<HP2V&C9*\\UHDOV9)35IR=YK,9"<Y
MN<E0@G*+IB3EUR()';QEAH59>0#D>%+(0]I21(GDABZU9H%V=#%XE-SB#H0I
M2>!=$'@1E&3P=H!,"3+SF/*(X 2;J<QB1M.9DB3FUYXYS&ST0P-YU$#.8'<!
MP=WRG/*!Q@BRMDAN^&*5F?RE*"/I $A^<I.@_)TJ]5G_SPAV\I21Q*0^*?F[
M'?"N7 Y D"NKX1XI)L"<Z(QH;@K A@54X8I)\(4XBLF[#8+RF0+UY"8IN$5E
MZ .@J"1E.$X:3'EP$Y32R^<^0RD/".0Q/[:LI41WBAAH(,&B25@@$N[YSRZ2
M-))'/:A!F1=3##K H$_5Y.\@F<E^4C*"NH,J!0&JNP[D<56'U"E/Q]H6<ZQ3
M:Q;5*#"U"5"N@E*:7HSF2?=YT%^6=*[&Y.?70"E03F[3@?+@ #CQ)L!#EI.L
MB&W+-Y# R*PA0:!0S:ID1?I4NG*1>%H-6U1GVLFX+O632@UH50V0QPC\\9S[
M<%UB5TL6<ZQ!!%I3(!LV&E/*__;.GR[=HDQS"[S.5K*W(QWH-5,Z/)!&EJ,[
M\$[ \F@ 6!I2K*R-KE=^.KNML6%XX?BL4R^)2M".D:0PO6HED4I*9;;TNUDM
MY?!6^<D#&""%D>F'<Y^;,.G:MRNNS=KLJG!=VH[WF<9D9G=%RTQ*3C.#"#TF
M*4'J6:+B\VNXQ>WNIA<!O/U#-CR% $3OR^&K4$&_*+@=9.MJ59A6UJJ?M"?Q
M]OI N.(3GU2-JG<[N<EL6. #>)L08O=1WP[[>"H7TR4WUH$[2P)8I'&]*S]+
MJ5M5#G.\!A;F@44+4)#FTXO9<  [*NRR>2B-K(?]L9B?0D7:V2X)N0/N)Y=*
M4X1"4O^DUVPQ/6/,R<^B$9( [>N)E_HU&>7Q TXD*W3'3&BBD&!VM4- %L7!
M16,.UW?9Y2AVKQGE@/K6R, -;USC#&#-;G)Z%<CCY,S!VH<6^M1&06#6JJA1
M>Q[5P.6MJF;UD5U2CABX*T:OC!LM3]\]V9(,$%(>YZ%:Q&H8U<@."@EXL(XK
M+@ %#2377$.J8 *_%:^8?#)!#RS-WK44TY[&[2J5T<-YY'$"JTML.C:<[';C
M9-GK"#$WDD"%LN49JP65<UMK^\5*;I>O<66&- 6:;U@3;UQX=)D'##!.UDK-
MW1"_"0G8L(Y=9I2VP#4I2BU=2I!"V(*@M7(F&4QIDQX4LI;_S 8(</RR0-O7
MU!&/>4R@45':610)XYKL@'6+9ULG^<ZZS:ZO66Q5$K,XH%-U\1:5E0 )N'*'
M'1ZTS*=>$F@P&ZU)&.J2[^G1G'-SE"X5[8,W3FGV/AC.P@S;-\_M\ON&F>IP
M-TD!1M!LF\]VO9H<KM&!F5?PRCG@F#6[9$],WLH*E ',,$ \<ES8J+,[[I#W
MB#F0 %MGWWWD:I2JK4WZ\X ?6<$DWWI+%9SI:E-@L"Y+@#P*_?#(N]XC:\A8
M%6;'ALR?\=9'U>U2,YOK)F/6D]NMM(ECS0P.;"#'@R(TCU_/?(VL08%!7<!U
MG1Q<R[ZXR<B<MH,Y*>EM<E2\U69&_S8N<'R7=: <R%YW\]=?$1\$=?;2'VC0
MMQIK%&-0I-Q%ZC+![[O"$QVJM'9P_= J>',!0X1LK<=^"N@0/@!;*# [N)-7
MN:5>VW1R329@+O5]IZ12C19-X\)QOF5P=@1?&Q >[09S"YB"">$#"Z1+1$9'
M2957@W=TFC5\I4=IAA=P:B924/5=P<,,_I !I05U<O$ Z5844J>""\B"#T@[
M$8A_ 69BX-=IUS1\$SA&"]97!U9@TO-,8K,#%X!ZU9$8!4 !%78!X\0>#2<0
M^M !$U !KU( "?"&@08" M)X V&'$R! #% !&7 !B,,0;Z>$2F@.9:9+%Z5%
M%/AH.M>!0O\73\TD:X:7=+[3<X$W4$\5:G@3 ;.$& 6 *0NC.8?QB?&PAM3Q
MAQD0 >;R+AK  1.0#^;R)Q @'& E$.: 0A<@'.! /A[0 >TS 7R4$"A(B"J8
M#4.V2+=C 8SV4;['C&O%/+YW3Z3G:3,V>E+X20UP 4Z'-QP0C'$A#N?  /*
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MIE$;A7:A6\92')7.+&6Z56E&YC4#&$Y<O+^__-2EXE/Z=7,?B,CXYLU&=8D
M1E)2##9[QF+%-[7G><T^:]83,W?KB@"^$ ZR',*W%8 $:J]G"[J =0'U>YF0
MS,+JQ]?0TI_MA !LL-:[QL;I5<--M6"A%=.V]DLNI<Z.C'XB[=22/1^IBJ?6
MA7&;MX5ZQ6GZ]'GBA;@?)7[5D ^[;-:KF]IZ,@#/)[3QAXF<Y:"?M&\H)E Q
M1E+*8@#;:#T@T,Y1)-T]4=:^#26>H$!];+)17,M:_[AD,^US<):1T>@U 'MN
MV8!8#9  &; Z5#I?^@ "T5T0'(G0YF@!(&"?#X#?.?,-!P "CTT0J'W=NN$#
M%GP[.K1O%&AXE*5B3S;0X->\FE0!C5TPB04"L.$!I5$00I+>XO$GHU&L,0)
MR= 7#G 9'Z#%&1H!*7XA[N*L(8"MYDK@>\*"L679[CIMSGBX\[K5^S=@,^L
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MO+QSIKUV/3GX)ZE_+OB^_H8NR-Y^_0'U 06XASR-2CA&&NE5ZB<PT5.2XL0
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MZ@$,"'.P%BG /$CF <Y&8"T-84 %' C!@SA@ @U@2 %2:1#3YD,#-RI .2,
M@9(^0+87R,TW0/"!")"6>P[XW65E^C3)C,\R\LG7ONZ&M?7D21Z?+)DKA8N1
M!E2  ]_(ZUT5HMH)0* "%?" 7<2I 0^0U2 <$  $V)*/"C@ O0,9P#XDT ^M
M5$"[YJA ! X@E@001*$<<, \ML(]P4[WH2&!6V4<T+J,'6EGL--'%C\%@D,F
MA7X&;DHY2KJ0 PB@ .'@P #TZ]\^?<"R#LB'!RX,@ 1\H" 5F,!=-N /_WK
M0 ;9@0#*UH_P B "!@A.N+@G70P/\T=5O/_AFO36Q6F"!JN.C1,/F0$!URRT
MR!UQ@ 9NDV+.GH.D#/%*-AR@7KL"0+7[Z(?@\)J!"W2W(!J81T'ZL0$ ],/#
M!/F&!ZIQ$&QX(#<%B,= !/"E"FC@(3"]\C+-H0\;.NH 6]M9)]6G.00NF $,
M (%8A9SHC639 A7@+6_9NV&"/("WWW4A*0'@@ $GY (:,*1Z"1*!%7>X ( Y
M6 $D8):"0" "!8&&!T"0#1T7Q "&=L@^:,QI9I9IEHYR@#1+I"LC\3* 0SD
M!';W 0Z0FMD2^<8RH $""T#C >I0@#K.N) &)$, Y]CT621@7@:4$0 3Z"\
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M^AQ2U @' (']N@ 5&[J$.,.%>  *""[_@#A:W!Z00)XJX(:3:(?RV)2-ZYH
MHA(C>@T#0"UB[(@.N#]3&45K))SO@#[R*8^,^A?T:;*=**+ "45NG A^B#]#
M.KA4031U#)WP 9(AT99*8Q*-J;Y>0CUIU #+DL<!$9H5,L%4V<: ;)HU.!-F
M41.0ZA<,J9VHTR3/H##_UYB =$1(ASBKV/L #>B -C+( LM(M1D 3SA$:'L>
M2>$4B[FG2TN ^$&*<^"^D8P(XS".XUB5>*1)LY$0=_$?)=N)O*$6OJE"/:$
MD:H \]K)A[@U&CL E4J5I%G*M>E)N$D"2!&@*N0:YCFA*;F/_+@ 2FR( 7
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MLCFK_Q\3PAZ</<WZK(,  0](O,,E" ;0@!#8AU%["*D,73&9JF.$'-RYO,Q
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M67G-Y!*S#M!;9881 O'E)#2' P !<GOI3.4P 6"/M!M.MDL(A>(^;[ZW&&N
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M"<" @66QAYYB/YM? _CW%52(Q*2 #SZ T.H ]=-- \"0"MB':LC-:7^ OTD
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M.C0>ZQ8X1^"+0==_ L9?@';]//KTZM>G'\#^/?SX\N?3KY\>6C(*ZNRCGR=
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M2T_? T4S((X#;*B*LLK9F .?#U4TIS(*O?]'P?3IJ[_^ .5,4,'=!4 #U_^
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M44 &!Y3#8T" &!J&*4U>(0X&!!3&84CBR$0>9P3&8"0 "$"#/23 [W3%\SQ
M.MR%.E2#7H"%7;#%CL&)6M"B/H@ =)#*0GP2<_A"-,Q#!D#)!,R# 1Q !63
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M"T/X0PC4! -\ #\ QD$(RAL9(?^5)'MLR*N,1Y(=QX8("H+\0]@Q9 N:H8F
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MM5Y*) 7++?^$.HA#RR2%//B58-B.;9GFC+*1.7C"@I[,.R0!$O@"&_" '_#
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MD3XPS22AZH^$ P40RZL8@+A"BUON*\BRB\K]@P=HP = ZUS:D%>Q40$80%;
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M$4'#AW=0:J*0X3RLJ5;P^T*U'#4 ..2#3:^S0VWU?/ALHN_K,H3 S8#+YPA
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MA5#"3&=@QN?DUN)\/$"DP_ZF*E4$?( '&$#4R0=P.DA"5@#)MQ-1!<RGP^B
M^4,\ $^SV#T "!A J , X,$_!P \@!@(8$*%A0\A H!P(&)%BQ<Q9M2XD:/&
M ND:#.@XDF1)DB38K%N0I JW!3RHB&/F0-[,'?+"[6!6DZ:RFO) 5(@G@*@
M"B8O*A")=*$#!DRA1I4ZE?]J5:M7L6;56O)!! P'/)@S,(%?U ,"#O2C4&Z#
MP@CSRC+4,!"$AZ<%(NPCZ.$H@ L1'D!DP'=@@@@% '0(\0V  P_]-B:@N)4R
MY0?H E?6G-'' L\H7";QY4 <S7 X4:/>X6 G:V8</!054.%IU0?V,D.] 'ES
M;]^_@0<7/ESC! D'_EW0<%@J! \:/D28@-B!! T))N0["*# O @)-&C(#.)<
MA0H)!U+PT""]!_,2% +(%B&$X0J,-2:P0!PJXJW0$JB-O_^0\(R; ]?A8;29
M5-MIIIW"80TG!@[(X!RB_O$  O^J4B"!W)BZ(+X!22S1Q!-1[.T #8(BZ@*J
M#IC_P"L.&[A@GPM +(""&\MYR!\#$M@.@ ,2@&:A X"4YZ$';!PQ/P?,25$C
M$":X@$, &!!PH0<HH("]@0ZPAS?NNJQM@ (L*$!'>RC(K0#\(KJRH@?\D3.X
M;'A0"33/V" --0CE86TU!A^4IY\(BO* @R^O>B =$)%R2LI)*:W44DO?Y!($
M.YDZ@(-+'Y(,5(A "*&""38<B($(^EJH@ HN8&<"I7:8@((J"S/ '@T$' #
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MF\O^)(^KA: HQV%A5@C'P:A0((?%M.A%402@BA+S CY+UPRU!  W$@0$<7G
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MC,UA(!JC%) Y.G"V/1:@ PV QML\<&9W R #A73JBS(WD(\#H%8#R,!D@@(
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MTR;R6FH"<(JB"CMB<TJD1N R(OKA]2:S./D# P2+O73#QB0@ K8I 4@L'SY
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M02&"6K<D(1I  (0$/&9OIXCE8?+4%3-  R; 72Z&(J I,SJ 6-SG1TT'3 S
M >8T_(+&'#RA8T&#&T:C"85GJ<8(PABJ*+ZU)!@S9Z=" <Z,&HU7<"55'9QR
M(Z?B8#U%\APB58>$<27/+BW@'(8D'MP%59\& TQUI[945_\E=#)B-Z(",2"
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M[(^[K$TV.K!$5/LW 90I_ %F8;U(DZLHE-;A!AT$?/ L*&)->W7:QOQ@P*P
M,D!\^H4[[KT (BUVIA0"4H=@6DY_AR. >XRS#XP*>CID5UF6D*JW$@6Q@SP#
MJ)MY#+M3R+W<];.W[V4"L/>BIKHD+" :)/W6% )8QB8P'*#6@N55GB(>JR[+
M-0 JD>A%&A:)T&$X%M) KIH-#B!0KR73'$@>&H #1EH /!)%^IPX%%%9&^
M*E[CK1(L*(("\F'IYX@;3:)S-<+6]!&F"F!EU7P-DJ# ME(TQ*&KF_!W([+.
M!\NV+0K _]Y2ZL/5,2@"!"3@Q<=JT.>H 4;@,^Y&$_F&JY5*MUX#];Z1*A(Z
M*BD8B!K  ?2227#-B9H<*UA46<>=[L$5+"#[/#A M6@=5)Y<CEPR@5C)S=/^
M=^69$^.N'T*@@\=.EIV37EJ0A^?E8B@@N">-7J), #(>*]H!KJ6BP34_4G=
ML+X%A(,FY$4KIY&PL12D"?7ZZ91J!S!  A(EZ:LB [:# 2@^AF1*AKSX (J9
M @39 E#VSRP[(LQ<:_H!/!\_G;7&K +TXK=>'#A [(M_,IG$<Q[&_P&BGSD
M! L:/(@PH<*%#!LZ?)C@P,.)%"M:O-@P6Y)U"U!PXU:%C0-Q#O^8R9,7[F3*
M'2N9E2QY((2 F0(T,,#H,(0#@OTN &A@$\"!"0\21$C P8.!!T,O5*   (0
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M )Y"O!U,QP(X,]FTWB, B62 8QCQ@=L0D(3_#8J$) 52ACZR9!*['<@D!O
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M-4&,61D4O.,_!U@FU#N#J'\Q8)L96$V#PXZ0.M9X(@S(/.QOC]!L".!+;!)
MN HB,1+'HV$,(+-3.]"I"A319 W F5.158!Y6/N ^0";FU3>$,)71"P  (<'
M)*(!?WPC! 7\+-2<MA,'H/>3;@%!YBO0G0L8KB'\D"M_/M)/0JT2;R1,%$K2
ME/\4-(%57)=K=42 /V9'N*> O@0"(>4!;W(0 Z !MD<C$: !855%.\!1&O !
MDG=  N Z4O8!%B@.4S(!%I@/!:<0VD<150, .[!G'[ 3%6 M%> !4J0!Z, R
M6Y0,\>!N$[ K%( J77$;/\00ZC "I%0%"+  -T424%<H 95*I)$-JN(@<K&
MS],==!$U6>B%O?0 !I !ZH80 G80^@ "!\ _T- /$V)5;5$0Z@ "%H"%[',
M(* /% %?.,$ DE< ><@A92&''+!ZMZ$N[F9).^%<!+%Z)C-)R_,N"^%%2YA;
MEG%7/85J4)A@#3(3'@ "#/>%ZU0.1_46;$&*H8B*,A3_(W0Q>WG!@DCR'EQV
M$$<'*'3% ^!@&H3R= =R8"+4@#1!/:E8$.&P;'Q8*L*(C,(83+YB 1T #0E!
M GQ"5Y7!!@? #*315XA20@?B+YS8B7F7BOJ0 *WH$ WP/\F(CJ'XBKY2 &O
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M75@7!4"& NJAW>1R&%$?5HD7ZG!;EZ$O_'(H>Q5"+H%J!^ N-.$YQ,D==O$
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M$/WDKZC6K_L$?8T*=O^??B_[-C\1XB?_L@L0$"XP8R8OG$&#V0YH$-#0PP$
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M5EIKM;56!QR(]59>>_7UUU9_ G988G_-===BDTUV!ZB4M3559IV=U1]_'+#
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M QO94!, *B A^03' !H07S_P>$A$)E*1ES%=.E"R# FHY8\ L-0!^-*J"3
M'=A;9"<]:97GG,1 "BB'24:(MI2@T$ GJ4@*KZ8ZEYP$E6A2P'-<>;6;?.,Y
MY7CAU48(RT)!(X:RI,@M(V(.V A' ']Y@ <*!TBE 8 X^ZA !IYG#F-&!!HC
MO&%-"K!-4W833;^T22@-11%LPJ8 P"R)*ELYRE#2Y!NU_S1E/5\9$W.<3R*L
M-"5L^)'-=2*R&A*2B!O[A\$"0,!^%: +:7;T%09H (0>8< $(O"SJ@R  O;+
M9$2FJ(&.1J0"'70)"#3 O]8]16<12*D%:K>VB(# 43:9@-^F:+]HF/ !$]!
M!8J$IA L,24&C4 &VB$1DY+I3Q32P)^>1)&  D =D03 >0Z0@'\,J!\= )(#
M"#:1BAXT(OXHF3TP2)J)IL0!(>!?2,VA-3*)0R(/F$=/JU+&Y\'D /:2TTD)
MN<\(A=2/G'1)1.TGKR16X+"=Z<=)85K5F<:$ 3K#J$0V*@'![K2G7RE 4&'"
MCPX\%@ ;C8!@J_H!I4ZH9)2Z0/\"V!G% _PC<<?[&3,HL(&HK"Q7'\ ;D$ 0
MT=R6K23JB$!0#V"GT6X !&ZLT&@EF@#M[4"B,P$!I!BP#[XR(!_[<%? &."G
M': (31-(*74%\#DT*;95'Q@?Q'9*G[[,D23RZ8 \')"!?!0I4S=* (.\$R(*
M-#<;6\1( S:@ELXVA#Y Z@X$0D#@)$J@ PS(G2$?\ $+?'<PY2,I3,:3@%S5
MCB44 (\^YK$U  P@&@P]6$0H($>:%( H W+ /P:2  \,*, /@*Y[-%#*M[%,
M'R1N#Y":NE?.,> #/Q%O&<OK$@44%RK7.9,]SB$8GK+D&^YM,0#B"Q,HI?0"
M5V;N5_K_ 2EF[,-'595H@%GRW0G2<37Q("CD)/ 5#373D$_AZP,(W#!*-K<E
M[<AQ3..!DCX"H!P>:$\%U**/#W"MPR4!TNDTT+2A."X$_U.,!MK3CPF(<WL?
M^%FE_A&5\?SEKR]&4P:$6I(#W-FC J@& 'HJ$7IYV6TR_LL%TJ&1=7DT5_ML
MDSD.<"\*>. K[-# -QH0(FE29@<9>&U*0#!;^.G.UIH9@#,!\(TRL9EV.ZC)
M!20@@39-0'L " '>'$W)2/N1 O(=20(V'9%![LM]5?4 2A;2'T\# -2B5JL$
M!@2.?@,@T6G"!NT@PNH"N/HE#9A'/#Z%I@_0YP&H 8 Y:HIK_[5< $.\]O+I
MZNB ?&2FSAU(AIQ"%.N? JD\WT5)--2RCTF#1!X>(/?A(F .2X%/ TBJ0--(
M(Q[SS40?_5;B Y!I:[^=&0#25<P$#$F<FGC<  ^+Z3\X>V5;/_QS%)!>+%7(
M'@"@1R+YOL#G_/R M]?D<7P6$(K)*\TGST27<_6 /QX@@#]UP&W@-J1,JUIV
MEQS7I-WK-O,R[4>C5T@>(:"W2 H@@0.(YR\L20#=(I*-> QF(1'Y*]9EP@RE
M*=0<R#MJ1$* )" ]'$-D![,&Q"&!'#G@')N*R 3BTLR4]K@O +!. ^)^1Q)Z
MF:!82U*.0;2,B S 9!T/ 3;4\8$#1/\TK1[A$,(B )'WR#4B'9@]M45NI+PG
MGEX\[10 (G Z?P@ [GZ",ZAMHC4>K\_+LL:7)%V;@0L DCBCB?,HH7A@K0@8
M@(5X '#0 '-( "]ZB1#XETH1@*/ZO@?(AUP)@5G""0HX-$M)D03( ,6HF668
MA_][M9(H!PW @ 9 -T4#NP]1MM$*@0(XOPI(OY2PCK;[@',X&P#8ASH#/N*C
M/Q2Q/YKH/H4"/P'H'I$B*(@I!ZGA!P@K+): D[$2@'WS(PSYNZ7Z  7\ -]Q
M0 A4I())HO9["C4JF$,!$NU9JR"9@#@1N;P*B3%CO\$H0(G@*32!&NH9O0,X
MF&KSB/-8LG+_N*T#6#0> 3PV\[2N*H<*D)WM^;X@1"\#B( VS!CBXRG;N(!_
MH8 .T,&6& ^UB#]*@0 )*(<!H) 0$(?O*@!F\+WM\X@+*YM*\HZ2B1-KFJ()
M4,&7.( -B)/O2)&Y88F=:K<"X("QZX $:HD>8P8)Z)[Q2*G<<9\"\,,&("L%
M%,278(!_8+0"\(=S8 =I&D)O:\3P:"I(E,27X(!SP,.JRBJ)Z ""JB@-B(9O
M@(!/#,67^ 9&BRGY<QP)>8^ERJ]5!*D@VAIYZ( $F,6E$1 &8 #8@(#EDX#3
MD8=_<  .,2'I\QNX>XH0* >1,RE?A"J(1 EXB0K9R(;W<$(_T@ /_UD]EI@'
M#?H F:+ D8!(!C"'?K@X ,@ 1WD_.6%$XD,)<'@-WZ,0)AD)$HI(E  T . Z
M+\N'KY@7S2 A<V#!P&C!#VA&D-#)B=BYF;K%B+B ?.@E!B@EG/,S"GB9#B0)
M<!L?2E*C)$()4"N ?4@&#JA"FM@! <";850<SC(4 5P(D\JYCW  ,82??& F
M\K L#]BW=)*F?O@NF6JYPA( N4RV+!K"8)PKHT1*"-2 I6R)\^B. 7!'Y5DF
M@>2L;, FTC0IK1&MDCC'GDP1 ]@T2^DY+UM,2E++#]( LDN=*)J HB@O#>F]
ML@FO,>0L#2"L'%2XP8"8C["4AH@'(ZFS-/_),-;L/?22$PQA![=1DD&\".-L
MB%P1@-*DD&T;2G4*@8A$L8 ;B?-HB IX#]9I0$=,-H1ZS(E(![4(.%;+R?P(
MR*HZ!P,XE+^CE.24"'&H$ K8-.L8P)+P/4^9((];EPAPGPD@+)C !J.0"-XA
M1NEI+6F*DQ?3)Y( $IO$!@B(!PAP '\4,\^;"/M+ "21APCXJ1WTR;WZJ+F*
M!][T*/C4+H 319#@PX@H!Y8*P3W4OXE AP!M#PK(@%CZ1S6D"\$C/NY0+8IP
M $<Q*>+CRR;2!Q   0L0D0O -GNSK*V1CS:QCCU+DL69E[_ T8\H@ ,X4XBH
M &R3L=3 4O<S.;S_"L+?^YJ1,-,S/0D!R)/QDY!Y6+?)L:SQ3, 3)8DC.M."
M(+\,R  /F TE.@<ATC:):( 00(F_,JGRK AS\(=^.%-)$0!RG(A<Z[UU$RD4
MU1X_B8G'JRIH0RH,T3X 2 :3BPEXP1[BTA?DFBO2_,GVL  ;= ETF >@U(!S
MB #*F#Y\JS./PCI *[Z7T$07.X>WHD$U%#]*?0K/DT.YJ+-OR =P* !!C8!9
M9594A0A5=0D/@*D'D("4RC7FBX@,@!V]A!RW68:FNJ,&?8\\T:ZXD+%]X(<I
M,M>(^(80*#)*[-"2L*H!>*" K"MHX(=DFZ !/;_C4M&4@!F4J+'V^(X=_PB5
M-"2^#^@>9L@'=9B7.AP)Q5",?4 OZT@&9%*L9$*'WE,+"$ \D9"/UUBG<N@/
M5/0W4I64YKHV2OK57_R']NA7X8H]XC,X6Z/-EW@/ U@GLO4C:*LNL?DJ:0JY
M[Y0*]\B'UAM9]1#4#]$>D\7$ETBVP7BVELL&JG+#;KJP[M$N0Z'$DE(CB;4R
M]_'3D!U9BGBWM3T<I,U3054L8<J= 8D,]YF4B5@(EA!3?;!:.L*NB;@ #X 9
M#?@I)2D9S*,(D\(@$&BW$-A"D7C V0@!+&V VFD-_RF #]BS!AA8X8R)G3I=
MU\B0T]4-V)!*Y2._5?T(\O.:DHF (562JE@(/_\=TI2 $@FP'P] NS+*!S.J
M5P"@PDB1PC\J5I>0C0G +#6]-P"P!Y"B'IHP3M.0@$^%B)T27RFAB-"EL7;[
M*YE@@'/8L"TS7@/H)AF+BN#](\0$"2BQJ-2-J>(B$Y>,".:%+G5[WHSX!AS+
M@-*H-?C972R<""79-^S] .TEB7]@'C\K+0_0GX@X0<QB&8H87N*;!WI47S'2
MA^=Q +T9(-_YH(H@B\XEXE'$ !"@W>#!AC@;HHD@G!Z*B>"YD2^E@'Z(H0,H
MS6]0&R";B6&3B&RH!@R@$@:H7@J@4)+ $1!08@KX+8_*#K'1T\YX "RN"7G
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M^_SDH%YKM@:)<!  "8&2N"AH/RLT"$B+1<.^GM2>\Q2T;D6+KU8U#R@@#=@
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D<SN_<SS/<SW?<S[O<S__<T 0#W1!'W1"+W1#/W1$A^>    [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MR;_]T:/_^O6''.7';SCM5U__X5=_9T9_U9=Z]Y=]K]=\;=-_44<_P+9!'
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M:G;8P:(,A?6LM/=LQP<\:=!\IB0J-.!+F>RJ)6*J0CVX<G@+=^4COZK29G3
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M3_JCG_JH?_JE[_J:+P&M/_NT[_JL'_JW+_NV__JP+_JX__F@O_K!W_NG?_O
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M^VI'S-B)<\[0P .#% 4* $ .-,\&.H #Q@Y$,,'!#$C '^20*\@ @Y"3$$(
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MZK-+9\D]I#/+.MG'6&2Q(K,R;H*]-FLCO^DH"63%@_DKU4&AKY(@AU0^=X%
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M8L56K<A3K4.OH[W.ZB[($RQ65+W*S)R\1,\++-6N@Y?6>YB,O+;XE%+YO$1
MW,_ 9+4 2I8 Y2C)+-84PYXH$D=RBE;Y.L@SW4B5V[* '"Q((D0ZF- /I<D4
MR  M<*VD+ %TD+=%W0]#;<+Y\P!GF%"EA"FE5(Q.\<5!5;=^,+AMT50=HYZL
M_-0#40![>)[Q839/++?"_$C__O+2>;1%D/NU!C2V!A3-4J12)#6G,QNASC1%
MY&/$[-%$'<*VQU(3B)H^MFQ2?=D<2\).6PV^Z$,A[!PZI5FS%P)$4FK,2*PV
MTK/2-H*AHPV;/(*K' 1-6A$WAKP7LZN+D#* 78RE=T6X=F@$ @, = @'<ZC&
ML/6S[U/1 = ".G@W_3"'1D"'HKS&234 ?UW7-U2C-&2JXDS8PT!'A*HML>.D
M--DCS6HOP^RZN;(][_2XBW4AK JD[8+..!I9+)6YCG50EE6Z')U(#!16JV')
M=XHCSJHFPIG9C=RK.]71&20LKA(FR,(N=6)</ZS/!B30T 4=0\*==N@@?'HY
MR^0X_\KA0YA2M$]I!-(<PQ(8%O@ $ 2SU^ %1F>0- 8P!P]8&7A]Q@SXCP[(
M@.%1T0R@"W-@5UDCVE,-"<3+6\9 I@D8B&?J+/\RJI!MKH_I+M UMX$TF)'=
M7+GIGE:<G[VB4B:UW\L\5H^:4GVCP7Z\NA=\7T[Z4:3UFZ-+.OFIOAYDWT L
M1$)4N?;"V52*,?\"R_D",B]3,0*57<FL4G'ZM-0;.AD,P&CT1F5L@&MDM$*\
ML,KZ4+&EH5A2UPS(  NBRK1;%/2[5-D!Q_\-7[FAN/)=#(P3X%)EW?54W>7T
M5I1;,?HLT")>&TMZW95<U1&<TZZRRM<%LO+L(^*JNGQY-?^3DD$7=<G/LJ!*
MK%WZ^A\\;#,FU2'0S:B-(ER J6/>JRE(9).L,Z@.(I8) BI4-<4$C11MNC4?
MO211"0)NK%X R(;9R0 ](SV6<AG!VT+ &\.#0]ZOC!%XU>2ZP#-N*^)A'=_$
M0^+ :*W7TJC#X0XE1=F'Y"^*_<B:@IG@.J,BKBZ'<D@3'KF<<9\3+LF" ;Z'
MI%62/-DVVMDQ Q'7247ZN<O#Y+V(\;*SDN6E&UPC])_<.]D*%)@2'-=F8\S_
M#;>X"2Z-8S9SRQC&I4D/"P ]^]J^VR8.>"4/!3]VH M9*AXUE2 .,(#;9 "X
M.V5['!F\767!0,=#7#$<;>2'_M'_M&D=I]4>]9K#8%O'QIE=M,2Q4#L]<%:E
M,,TV([0D:P.L#12YAYYB%YUBBMI,XS)<J)5(+8;#TN4X>=''T66L\DPC5QU,
M+[5!@/S9Y.LN&]-9DQG$W:7(1.*C$H@E1O,*.M""> M?3$;*V7G7#AB'<>@
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M%*@L(3@XW,;U? I>TL+XL-\F:L^IOP@,>[" "]!V"$!W?[@ !4!ZGF+E_S,
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M5^K\RA&9&4YMTC<F4J_ E X!S^WLHRA)#S1UXD-8H18%3=3Q68^%C?'0X<]
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MUF+%&18]JG$F&"N1' 6NWF%)VBI5)CO4S1060",T CLT!MF>1"-HP-DVPD[
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M?V(XLZ @?D-=A]6W7*7(<?Z.5[ON92_BY]6C;=F.U?6C3L8E>_C-*UI' Z2
M%HQG(PA (_3SFTE8TTT+!C8KF0& 04ID:A?.J (._-4Q1FON?;7U9%=X1VX-
M/]0U8V !"<S!!IP 8B@&.JR5<1< !-@G )2)@<@P/;CNZ/VI:7W7/Z>KN^G_
MMY?BER4?X-JN4/GD&F,W[C3BWD]+90DO#9_5UTL6[@VZGIZ\9+DK$5@?#UWU
M,\H%*&5OU W'"AF6Q<093EN8]5I8IRMRP-OU@YXNN@WK\?$69:'\8*:"[3<$
M20K4N@0#9+,O^WD7>X>'\UNO6MOP<7U8 ,?. 0+@M<1  #_8PP54J9U   :
M SXPIGXDICT,R& \-\! K;K1;&H=:LI%]3EG>@T39Q8IRU ):CK:GTVO9\O#
M==5'+7,B\/^RLN,"*/$Q")]),B(R8R,J3[W00=<:(+060#F%*EC8W34%@=VW
M4Z9R@/7$3+ @.I)4)/MQ0 >L3P<<5%PB80DD9.$H_T!W0B^'9[Y'8_X?Y?&^
MK_PP>2&T#\8)F  _8($"8 $,;X9])@ ]#$:W!\!G_$< T$& ,'T"A+N94 F-
MN A1'1!#K="+^#Z$N CQ,X@1-8B1](B#^/[Q_SY#/;_P0W_P%W_S7W^&S B$
M)+_,-(CT _^);%\O2O_QHX,CF(.09,"/A@60WFAXH#PXP!/& %R&5$2[K,]2
M'3\'_"# 3J3]%P! L"O1H!\%#Q[Z#:#0H 0 APX+/)0((.+$BA8Q3J0H\>+#
MCAXU<@RY421(DR0U?H3HD)^$ "]AQH2)  LAFQ8XR'PIX0* EPD,!$"@#H*"
M !PN*+CP$H// ! P@%-@ /\!50-3JTZUBI7.U:U?LUKU&M; 5[%5JXZEVC5L
M6[!ET:J-*Q:NV;5NWV*UZG8NWKYOS?[5FS:N5KQZ!Y]5NU<L8L9QV](ABX"M
MU[41&*MUG'9S7JKM,C#P,$!+.["FVQ&V6H(!@T8=1A<<C7# @'X>#/9KH*4N
M@@(92G20W)NX[P[C&);MC8##0-R^J[;30J=#@P84:A=4Z"%#H\?%P7]7/3[S
M7_.*(:,OOYZ\^O-S#?34.3\ /7L)C-*'T YF I_L^"DJ  "2@N GEPBT0 $%
M(!"@00<9%" >"(JJ$(()(ZP0P@8K9%!#"SGT4$0*-]RPPQ!19'#$$E$$D4,!
M3%S_44,8'V11Q1<MO'%$&3/$\,(6;XP1R \%R-!("G?\,4<D4=PP2 LG=)+)
M$3E<TD8K/WP2 07"T.(@@SPH(1X%XAD3 D<H<$2!<,(I2@$$2D HG P(J@TA
M["A(R+;M* AC00H-LDZ+"4%41\5X_ 03(08HZ+ #( RB@ %G'"E*G8,(HLT@
MV\(,(PPI?0SUQ@G+/)'!4$VM$%4=?SPUU2/CD?)4"8LB==56+Y2521:+JH"^
M7X7R3R<%G'H) @0"6-   Y<%@)\ \%GJ)0,2","?B:Y]*%L KLW66VX=^E;<
M<,'5=J1SNR77W&TE8O?<=D-R]UURY85W7G?3C?=>>]6M_]=<=,OUE]]RX14X
MX(/I5??? +3H((M&\K2-T0X:.0> <S(P!Z$.\J2 C@+0R:(!!K3( #?<* C"
M@$TC/;D?A[4(H!&$<#. @X="9J ?=CBX5HLL(AU M'X,0 < =#+X1C9)&: C
M9(WUW%.[, &00*-O"=YW7H"W[KKK<?/5.B1TPBD6V)@L&"(HF #8P((+F+4X
M@0OL02> "RY(@)X U*D@ 3IF2N!FC<!QR.*++[(X\8<.!Z!PKQ$/Z?"(*+]8
MHL//J>AQRR5_5_&5#'=H\\8Q-URER1V7:/3+&0_=]=19?UUTUCMJW/6*;+\]
M]L]SO[QRV$'7B/2'-D>)\\\=*O\!N0SP/#E3"G(3FN84F(?^H$:T&'J HNG0
M]#9&<6M@G(:Z!S^+BD!VC@Y_(+;NMHBQ"X(B#L(Q9P#<=*: '@""1GFT2!N0
M!71<9',7T1Q*,%<YW)EN(X6+2.DV\KO'?2XBCQM=XB3(0,XM#G:H QX''\(/
MLYWM)14@P=I@4A;,),LH #" 4]#!CF*5Q6XOB8!_7)A# Q2 <CST(45^V(YS
MM".'1'RA$768Q!<6 !P_Y&$3F^A#)D80 $04HA6K",34(?&%7<RB%X\XQ"Q.
M48I.+.,9>9C$,D8PC87CXA>S:$4I-A&(:)QC#^=81Q]&<8]P]"(6_UC%("JQ
MB*E+8Q[_"Q=&)"XR=5ZTHQ;C1+.6%61HN+D?=FQCO8/<)@CGB-0..0"QDWD@
M!5K SFT\T( .\.\V#*$(.@Q0@D % 1W5.1EV+#F ;S1B 5FX#:<DY8%5QNDV
M)>A*G +E@8\5CHY/!*(#%7A&*DK3@6Q$)!OU:,@Z;E.*V/SA$8LHQG;@D8QX
M3"0<VT$/=8Q0)_0($(4@, ="% !8#B&A3MB1@&QE#B2_.R1)(D)$;?*S@@W,
MHABG"3KT55"!"<4C%2<HT-_1P2'TB"85M8B^A%(1H0H$QPLS.KN"1@2D"G7H
M21L:TH9J]'<@1:@V#0A1DD!SH_^TF$1AJD6'@)2E&Z$3^"*E_Z>$1(I1"1$J
M;H;:@$8 P /F2($_"K" [AFU 1DP@/?"U+WMI* $)0A'$%) ,RW4LDY&58B>
M*#80VZ0@-Q[( CM&Y@$M ( #Z(ADRAHQ0(=>])]\S>DA>[A7E7ISI=,L;$\Q
MVM?!%M9B+3D;!(9 "!)(UB8HO.=E$5 M<':3B %U2&<+64C/CC:+CP,M8,?X
MT#8*5K&>!6<.26I-PV[DM&,TK&<%>MI:#J $2RTH%CUK6C%VL[6L#6EM*X?$
MV(96G!MQ)&QE&TW5QO&SM VI%[58VY7=DE/4NR50+:F=EKD2 ,#) .4X0*?1
ME" +='B?G:CW/IJ98QS \4!K.I"!L/\&\R"6=!YM=J,%UJ"L'PQHR/P&PA!T
M+&"-K5WI80/+5PC/-L(25BGEJNG,V&XXHWZMG!OW=P!VR@0 "T+ B;<T@<NN
M.%@2P6ER89=AV,$XASG%:6</N]?15CBDH .IC"4:X0MK$[0X):@A"] (@2"G
M$1SXH3:K2<2.0H3':<2Q-Q,*W"P:=+G,]6>-Z8C<'(\T=6X4Z8,-*M"CQ4EG
M>RI!!H+@/4Z![Y+X6T@&!EA7!O,0':8LP5@7P([[1JP@1)VD]0S"@.?UX\^B
M-.NF<$,'#G2@J+,18$6TP-4,#!FUT^UTE='<:4Y3F+"E]NN+.USJ)<[N OA@
M\:M?G<\ A!'_NDO\'!8S;.;'\=2V0LSAXT =ZK\F-) @O7)%5MW7RAG[I-;=
M,45T@ZD.,-C9O;YI=1V,TB&O&M@441R-D;A3ZCXYV3"U,&E):V8A_];; *!#
M..C FO[);[L).9E]"RW)FDT7B4YF8L3"FYU,6E(TDLH3_E1Y,W0$ 7H"ETT&
MG*:%ZV2GJOY>B<7'/&I1>_C<J0:UQTD=V-RV>^-8;JA 10QKE=\SLRX6-XP+
MVNN5+!>[U=RR<D&^\8\KEH)$GK')&YHY&$=QV 4()3 /H@4G<QFC N6UJ$^+
M[@D3,<S5?BEV&;A<THHYU=5T*;JQ6>Z -F<<&@OJ06C)OP:<C %X_Y9E!NC4
M@.V8 \\FGSE=86-O/-E[3_![])<D#40#=* ?SOA?51^RLK4'ZKR+#3:%)ZQL
MNZ^;TY%?=TJ;:=N='S=U^VOU/2\FQ!>"8^7 RNRL:US2VG9VUR]/_4QM^V-M
M5YFU0C8SU6V;8>*J-,K.;;KO>UC+;P13-T&XF96!#^:7C_G#MPUIMQ5X:\N5
M-)"@A6XU=2]8IY?V[LC=XBLI'?"$M!V(00@",A&_/PX8P/QT8#@%.K!TR:.6
M#O=[\R]QPSR!@PF3E#2F%OMLD\"DR2*" TH&3/IAT^8OYQCPTS2NXW0.\DRM
MPQZJQHXMYS L@L!A?];IGC: LFR"$$[ '_]*;SY:SG"V#Z16[<A44-P "KJ@
M*]M*S@$M3Z2HJ,AFCN.VK/G"3<W2:/WBA+=PB9;^"<B6C\(XH*X4"_?03,NN
MS/JPZ.ILD-=6S]0JAY]N[M>8#OE@9R# *Y4Z0*^,KL_,CJ)^"!V2D*2^S0KG
MQP"*J3K.BC2LXQMJPR"0R=XV;>8X(,X8X)+R*HWHBG\HX/\NK_8\3M@\[=QT
ML!"+JQ&M*\86*Q)1R[%(Z *P8&XV8 [L@1"DI01C0M9>*^:Z3<M^[IQ>JP>I
M:(EH;_XV+XTV*P:Y+-0:2MW&Z'!\S0#FRNCH( 4*#F)$HP0<,1!1"L."H ,Z
M8/0J+_<2[^>0+8?_KBV)JDT+OT_&H Z._DKD2$(5 0"9)"8XNN/XYH<.%(T"
ME.W)- Z; &  S"$X#L(9[L?\.J )<J.4(*V^CJ]RO,0V7 FP(J(KS' 15Y$-
M*8\1C8L5:W#GKNT5:9#V'"+E2,@"YN E%  + F .JL4380(=3K"1J OG? _7
M=A %(^?U,LZ,AI$!;]#UQ&X@8>S(7,LAV.$V4@ <NB=3,D#B9!)D!LGH@B #
M.D#IY(_#>"A0&N ?)Q#&J-!Q/,NZMD_<I&RY+C"X9F\9H^[Y=*HB3LEY,B
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M?A(XK$.8D&?50.OIQ+0D=W.#<>O[OG=V<(S] "A%0VT!V&R3MD-^:OA^$@(
M.L <HCE,4& T^BZ5BC(E:;'W=G=V_)4) 2 (1F8[&$)DSGD[J,;3L,S[')8G
MU94C\E>(^?E[*_5+BY"?/=:>[?F$Z1ED"Q*(_;2>?P=]Z<,GC&9 2)!9#12'
M"@!7_V.0ATC4IX=&T>*JP';C3U-*8_FREP-2EEN0<GK.EU,2?<AJE.;9,.D
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MR4EJ:<IFCQISR"BO7/KJE:KNL6C1AGIRRZ_+]!<]0,'J8&C^0*7T"5-=8"L
M]B"@3SP!7*  !/P0A4 "$X36CKAC*L:8QW?"!AD%.Y80KD)Q[DJ!9EC%/MI&
M%<WXD)_5D369=3T*=)?UWZ*E47(F[HE^_^K3#,!WK:\Q#WE< [*3H1(PH $=
M4%=$.+"6S]B&3%VI#CM&9([GA*9_=VK. G<#0 Z$IT@_BERW,J"QB?QO@"P,
MH LYR#X!OC!],Y1A"V,H+1K>T(8YA&'L;MA#&$J+A>N[@ 0<A!2E*!$+!C"*
M JB"*@@D  (%"  $&E0S R M 4<, !2U$H3_"WTF TC"VVG*5:Z+=$ R@QH
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MKGWOFSJ//#>[_+VO>?N[7/_:5X7:Q2UT!1Q@!.-7N;H]\($5#&'<XH- #TH
M(000  P0 FE&08<%!MK$*P+@>0H0@#\ND#04#X4.#FT(!H.0O;M5BTKNHPQE
M3GC;BW$@ %H@D[YFF\J'!*9:%%$G?<H)@,!8:RT(20%T*20DFHVR6T$BC94O
M)9%'9?G*678(DD=22?Z,,I>42S*7S6PM.D2I3B:"35?, <(NVPX RDI@"<+!
ME<A$)@N4S$HC@M"(JVP.DT6VI>W.5KDM?YF97);_\WT8S9(M7T2=+QJTQ2B-
M33!7SM*:[C2G2-;H)&]Z-"8)2CZ3TD0%* 6@RW.* NA CPM,,;-2E)X7$Y
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MK) %$G(!($*4S31T4/\4AVQUHG9I=E( BP80  H(' A.( "# Q4>5%APH $
M$,$5/#CQ8+N( # F+."P(<*."Q,RS(@18TB$%2^F[$@0I<6)'D$R7$C1X<P"
M,6NJO ESITV"01N&1-GRYT>C0BL:!3I2),F13CU^-&@1*%&L16G.M,I2J,Z@
M&TDNQ CQY<"-2:DRY7JSZ5:Q65OZ9/O1I%"F>;=RU.A5(EZ0,5=678LR;ED
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MM)E.#$50_$1/M!-3),53+$54'$5A.8=(I Q)I =7' A*E$3FD$10K!?TD$4
MX$5?W$5@9$5AJ41XLAE<Q$52%,9D3$4[$1-.7$55]$1GW$1J7$969 XQ80YF
M_,1?[,5@E$5$B457+$9RE$5=/,=HW,9TA$931,=Q?,=ZN47*,,=TQ,9J]$1\
M5,=QG$9AHD=)/$9C9$4[$<=ZH4=_A$5A#$7F,!M<1$=R?$A<D40F$Q.QBYX:
MD0P.^S4)Z!EY*8F1HJ0Q&BF/I"3$*,F11""4-$F5],B5)$F6/,F6_S&,0G$;
M%5DVC;@GE\S)OC!)2I*[GCP($ G*D_S)G[P+G33*G7Q)EY3)EBC*FS0)XHB3
M%3K*E*S*YII)(:+*EDQ*K51*KOQ*Q!!*I+P+MW%*IU3)J!R6ER**F@1*M[R+
M=L@+N6!+'N+)I.S(HM )NBQ+^0BVA5@J<\N,SL,O;;2SSJ#$9*I&)N,<MBF;
M#&O,QV1,R8Q,RD3,D3(;$R()_-JD'DD>:$D<Q]RD/W-,FES,=#--]& .R%Q-
M&B(I1$D<R*1$S*1&DF'-Z_E,8:%)SBB8Y@C-J^1,D6Q-X-REG7@CQ[PGU;S$
MTW3-V]PE@<(9QO2SS6"3H+O"(YJ.O I.M_],C)@QM]'+39*Y2N7X3;FKL]_T
M3?00SO-D3MO<).%4SURQ$TKJC6G4%6BY3C^;E_3$IQ:IH<U<S/T,.AHBK;!<
M3@&MQOYQ*?:\2L$2BZ!;L@!!C%N9IM"XR0.UT+B+3PM-4*)AKT<1%N$,R9"\
MT %5"C4R*(Y,"=&<N(7(T*<$3@X1-\CLR&P4EN$SMTSB)'^A1N?B#,(T#X.P
MS(R031 34A<]4@.%"")-S59A"9*AQ?72S(^Q"(M*T4E$%.24THSXB_4D49$T
M&R3U4LY1MB(]SOX$,<20*^?01.48#U(3B]8TTI&24^"D1"HUE: 1RDTC31#5
M3N!,4#5=)Q79)27_192) ]-T<\]\8I@W<E*49(Z*E+.:(2TQ\4@=;5%\ I&.
M=,F@(T_V-,WV[%(774\)4J</%:*DZ5-+30H]3<PZ4=1.]=,""- PS=!7?4WS
M -43O8@ I0C:M"4%98M=]551=4W2ZE3]5-39F$\M93(,_4@-+=%750@FQ1K@
M\$A6':E[(PTO-4W^28D8859?S0C ]+5,,E24K$8/!9&^E(\KI$5/]=(#M4QZ
MO4HZ=5$VK15V'0R_X-<GO8G?3".19!N(N\S'S-![LLQXK=72NXLL73A^Q"]
M552A9 M&#11-+0YY?<]T"TV)!=?%6:&%R]"1S:=0':D5ZLQ2Q=7_ %D*_ST-
M"24I@O56 \M,N4L,(Y/48-%1"(U9']U2_KS+)!W:#=70LCG6CES8Y4RQ_9 [
MT&P.['E.Y7S) \4O"+5. _58FV'8ZAP=.SG3J4S7OU#1FW55Z>30EF!::-E,
M?FQ;=W5;%>U,A1#9Z;Q0QW3,44U6TI&/DYBC=]G1-*V*FMW3*P10-U,C4 6
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M@ 28( 'J7.<Z,8 !=L)3G1:()SSG"<]WKM.>])3G/O/93W[^4Y_[%*@Z\9D
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M/SSM^*[QQ16HKFHXL05:E2,Q HPY'!\ E2>X4$1 4G&G@NN?SB(RE<]TJQ^
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ML7\L :$%XOB;BGBH<@M)GXI\J( "Q,-R (A  K8 %=C5$$%HZ=$:L==(OVV
M(A;Y'F<LT(ZX^(U,>R1( @W0L[=,!S9FX<>:\C) _VPM<7EZ/(A%1A<  XPO
M,GKI840LI4C91-*&%S =<RK'R",&:2K[(U9%(@F!)V5K#A> C5YNMQE2"J0
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M]K:YW6UORWG77!T"59P-@6F/.P"J'E1[O]UN=[\;WEU6-*.Q  !T.,'9SH[
MHA,0 4)<FQ!<C/? "5YP@^>,#NI9]J(@0 <Z+)L.XE (=$I\<(M?'.,9U_C&
>.=YQCW\<Y"$7^<A)7G*3GQSE*5?YREG>\DL'!  [

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
